Abstract:To identify potential downstream targets of Nanog, a key transcription factor in the maintenance of pluripotency of embryonic stem (ES) and embryonal carcinoma (EC) cells, global gene expression profiles in Nanog small interfering RNA (siRNA)-transfected P19 EC stem cells were performed using cDNA, 60-mer, and 30-mer microarray platforms. The putative Nanog target genes identified by Nanog silencing were verified using reverse transcription-polymerase chain reaction after Nanog overexpression. Downregulation of Nanog in P19 cells resulted in reduction of pluripotency markers, such as Fgf4, Klf2, Mtf2, Oct-4, Rex1, Sox1, Yes, and Zfp143, whereas overexpression of Nanog in P19 cells reversely upregulated their expression. However, expressions of pluripotency markers Cripto, germ cell nuclear factor, Sox2, and Zfp57 as well as leukemia inhibitory factor (LIF)/Stat3 pathway molecules LIF, IL6st, and Stat3 were not affected after 48 h transfection with Nanog siRNA or construct. Nanog silencing also downregulated expression of molecules involved in the p53- and cell cycle-signaling pathway (Atf3, Jdp2, Cul3, Hist1hic, and Bcl6), whereas expression of E2f1, Tob1, Lyn, and Smarcc1 was upregulated by Nanog silencing. Expressions of cyclins D1, D2, D3, and E1 as well as cyclin-dependent kinase (Cdk) 1 and Cdk6 were downregulated by Nanog silencing in P19 cells, whereas Nanog overexpression reversely increased their expressions. Taken together, examination of global transcriptional changes after Nanog silencing followed by verification by Nanog overexpression has revealed new molecules involved in the maintenance of self-renewal and in the regulation of the p53- and cell cycle-pathway of P19 cells.

Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells.

FOXC1 Downregulates Nanog Expression by Recruiting HDAC2 to Its Promoter in F9 Cells Treated by Retinoic Acid.

Increased levels of FoxA1 transcription factor in pluripotent P19 embryonal carcinoma cells stimulate neural differentiation.

Foxm1 Transcription Factor is Required for Maintenance of Pluripotency of P19 Embryonal Carcinoma Cells

Stable Expression of FoxA1 Promotes Pluripotent P19 Embryonal Carcinoma Cells to Be Neural Stem-Like Cells.

Pleiotropic Functions of FoxN1: Regulating Different Target Genes During Embryogenesis and Nymph Molting in the Brown Planthopper

Foxo3a Contributes to the Reprogramming Process and the Differentiation of Induced Pluripotent Stem Cells

The Mir-134 Attenuates the Expression of Transcription Factor FOXM1 During Pluripotent NT2/D1 Embryonal Carcinoma Cell Differentiation

Fibroblast growth factor receptor 2 homodimerization rapidly reduces transcription of the pluripotency gene Nanog without dissociation of activating transcription factors

Foxc1 Establishes Enhancer Accessibility for Craniofacial Cartilage Differentiation.

Nanog Rna-Binding Proteins Ybx1 and Ilf3 Affect Pluripotency of Embryonic Stem Cells

Transcriptional Regulation of Nanog by OCT4 and SOX2

Foxd3 suppresses NFAT-mediated differentiation to maintain self-renewal of embryonic stem cells.

FoxO transcription factors actuate the formative pluripotency specific gene expression programme

Nspc1 Regulates the Key Pluripotent Oct4–Nanog–Sox2 Axis in P19 Embryonal Carcinoma Cells Via Directly Activating Oct4

Tbx3 Isoforms Are Involved in Pluripotency Maintaining Through Distinct Regulation of Nanog Transcriptional Activity.

Foxg1 bimodally tunes L1 -mRNA and -DNA dynamics in the developing murine neocortex

Nanog and transcriptional networks in embryonic stem cell pluripotency

Zfp281 Mediates Nanog Autorepression Through Recruitment of the Nurd Complex and Inhibits Somatic Cell Reprogramming

Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells

Impaired Interneuron Development after Foxg1 Disruption.